Esperion Therapeutics, Inc. earnings per share and revenue

ESPR earnings per share for the last quarter are -0.15 USD whereas the estimation was -0.18 USD which accounts for 14.42% surprise. Company revenue for the same period amounts to 51.63 M USD despite the estimated figure of 51.31 M USD. Estimated earnings per share for the next quarter are -0.14 USD, and revenue is expected to reach 60.94 M USD. Also watch annual changes over time to get a bigger picture of ESPR earnings per share and revenue dynamics.